<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>50(2)</volume><submitter>Robba C</submitter><funding>Università degli Studi di Genova</funding><pubmed_abstract>&lt;h4>Purpose&lt;/h4>The use of arterial partial pressure of carbon dioxide (PaCO&lt;sub>2&lt;/sub>) as a target intervention to manage elevated intracranial pressure (ICP) and its effect on clinical outcomes remain unclear. We aimed to describe targets for PaCO&lt;sub>2&lt;/sub> in acute brain injured (ABI) patients and assess the occurrence of abnormal PaCO&lt;sub>2&lt;/sub> values during the first week in the intensive care unit (ICU). The secondary aim was to assess the association of PaCO&lt;sub>2&lt;/sub> with in-hospital mortality.&lt;h4>Methods&lt;/h4>We carried out a secondary analysis of a multicenter prospective observational study involving adult invasively ventilated patients with traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), intracranial hemorrhage (ICH), or ischemic stroke (IS). PaCO&lt;sub>2&lt;/sub</pubmed_abstract><journal>Intensive care medicine</journal><pagination>234-246</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10907416</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical practice and effect of carbon dioxide on outcomes in mechanically ventilated acute brain-injured patients: a secondary analysis of the ENIO study.</pubmed_title><pmcid>PMC10907416</pmcid><pubmed_authors>Yahya HB</pubmed_authors><pubmed_authors>Deewan Y</pubmed_authors><pubmed_authors>Robert-Edan V</pubmed_authors><pubmed_authors>Baronial A</pubmed_authors><pubmed_authors>Matsuda T</pubmed_authors><pubmed_authors>Pineda AAV</pubmed_authors><pubmed_authors>Garcia-Ramos JC</pubmed_authors><pubmed_authors>Samir J</pubmed_authors><pubmed_authors>Ahmed H</pubmed_authors><pubmed_authors>ENIO collaborators</pubmed_authors><pubmed_authors>Monleon B</pubmed_authors><pubmed_authors>Azab MA</pubmed_authors><pubmed_authors>Abdelaty M</pubmed_authors><pubmed_authors>Alampi D</pubmed_authors><pubmed_authors>Papadas C</pubmed_authors><pubmed_authors>Codorniu A</pubmed_authors><pubmed_authors>Tringali E</pubmed_authors><pubmed_authors>Biston P</pubmed_authors><pubmed_authors>Orquera J</pubmed_authors><pubmed_authors>Castillo VHN</pubmed_authors><pubmed_authors>Battaglini D</pubmed_authors><pubmed_authors>Bicciato G</pubmed_authors><pubmed_authors>Mijangos JC</pubmed_authors><pubmed_authors>Launey Y</pubmed_authors><pubmed_authors>Brochet B</pubmed_authors><pubmed_authors>Hossain MM</pubmed_authors><pubmed_authors>Maugeri JG</pubmed_authors><pubmed_authors>Mishra SB</pubmed_authors><pubmed_authors>Chantziara V</pubmed_authors><pubmed_authors>Dominguez RCL</pubmed_authors><pubmed_authors>Jain G</pubmed_authors><pubmed_authors>Kaye C</pubmed_authors><pubmed_authors>Serrano A</pubmed_authors><pubmed_authors>Akkari A</pubmed_authors><pubmed_authors>Bellissima A</pubmed_authors><pubmed_authors>Oto J</pubmed_authors><pubmed_authors>Rodie-Talbere PA</pubmed_authors><pubmed_authors>Masseret E</pubmed_authors><pubmed_authors>Cinotti R</pubmed_authors><pubmed_authors>Citerio G</pubmed_authors><pubmed_authors>Bellini MM</pubmed_authors><pubmed_authors>Saxena S</pubmed_authors><pubmed_authors>Filipovic M</pubmed_authors><pubmed_authors>Companion B</pubmed_authors><pubmed_authors>Daniela PM</pubmed_authors><pubmed_authors>Khaled A</pubmed_authors><pubmed_authors>Gasca GA</pubmed_authors><pubmed_authors>Hourmant Y</pubmed_authors><pubmed_authors>Lazzeri N</pubmed_authors><pubmed_authors>Lamot L</pubmed_authors><pubmed_authors>Zarka J</pubmed_authors><pubmed_authors>Asehnoune K</pubmed_authors><pubmed_authors>Yadav G</pubmed_authors><pubmed_authors>Ippolito M</pubmed_authors><pubmed_authors>Gerretsen BM</pubmed_authors><pubmed_authors>Soyer B</pubmed_authors><pubmed_authors>Geslain M</pubmed_authors><pubmed_authors>Agrawal A</pubmed_authors><pubmed_authors>Georges D</pubmed_authors><pubmed_authors>Digitale JC</pubmed_authors><pubmed_authors>de la Torre Peredo N</pubmed_authors><pubmed_authors>Ghulam M</pubmed_authors><pubmed_authors>McCredie V</pubmed_authors><pubmed_authors>Reza ST</pubmed_authors><pubmed_authors>Robba C</pubmed_authors><pubmed_authors>Taccone FS</pubmed_authors><pubmed_authors>Cerda RC</pubmed_authors><pubmed_authors>Trujillo RM</pubmed_authors><pubmed_authors>Samal S</pubmed_authors><pubmed_authors>Agarwal S</pubmed_authors><pubmed_authors>Enomoto N</pubmed_authors><pubmed_authors>Piagnerelli M</pubmed_authors><pubmed_authors>Astuto M</pubmed_authors><pubmed_authors>Lopez-Morales M</pubmed_authors><pubmed_authors>Geeraerts T</pubmed_authors><pubmed_authors>Jha AK</pubmed_authors><pubmed_authors>Mouclier N</pubmed_authors><pubmed_authors>van Vliet P</pubmed_authors><pubmed_authors>Sklavou C</pubmed_authors><pubmed_authors>Schultz MJ</pubmed_authors><pubmed_authors>Azzam AY</pubmed_authors><pubmed_authors>Abback PS</pubmed_authors><pubmed_authors>Elbuzidi AAS</pubmed_authors><pubmed_authors>Gard SRI</pubmed_authors><pubmed_authors>Biais M</pubmed_authors><pubmed_authors>Miranda-Ackerman RC</pubmed_authors><pubmed_authors>Elhadi M</pubmed_authors><pubmed_authors>Arellano A</pubmed_authors><pubmed_authors>Ueno Y</pubmed_authors><pubmed_authors>Garcon P</pubmed_authors><pubmed_authors>Galicia-Espinosa F</pubmed_authors><pubmed_authors>Godoy DA</pubmed_authors><pubmed_authors>Cortegiani A</pubmed_authors><pubmed_authors>Welbourne J</pubmed_authors><pubmed_authors>Grillot N</pubmed_authors><pubmed_authors>Legros V</pubmed_authors><pubmed_authors>van Steenkiste J</pubmed_authors><pubmed_authors>van Meenen DMP</pubmed_authors><pubmed_authors>Huet O</pubmed_authors><pubmed_authors>Gergaud S</pubmed_authors><pubmed_authors>Ioakeimidou A</pubmed_authors><pubmed_authors>Gaugain S</pubmed_authors><pubmed_authors>Al-Gharyani MF</pubmed_authors><pubmed_authors>Suei EAA</pubmed_authors><pubmed_authors>Haenggi M</pubmed_authors><pubmed_authors>Sarrio E</pubmed_authors><pubmed_authors>Filippini M</pubmed_authors><pubmed_authors>Haedo MMG</pubmed_authors><pubmed_authors>Hashim A</pubmed_authors><pubmed_authors>Vetrugno L</pubmed_authors><pubmed_authors>Pirracchio R</pubmed_authors><pubmed_authors>Pietsch U</pubmed_authors><pubmed_authors>Vermeijden WJ</pubmed_authors><pubmed_authors>Masui N</pubmed_authors><pubmed_authors>Coombs AE</pubmed_authors><pubmed_authors>Badenes R</pubmed_authors><pubmed_authors>Fong N</pubmed_authors><pubmed_authors>Abbas A</pubmed_authors><pubmed_authors>Panda S</pubmed_authors><pubmed_authors>Rocco PR</pubmed_authors><pubmed_authors>Sala VL</pubmed_authors><pubmed_authors>Prol-Silva E</pubmed_authors><pubmed_authors>Alvarez P</pubmed_authors><pubmed_authors>Gurjar M</pubmed_authors><pubmed_authors>Brandi G</pubmed_authors><pubmed_authors>Andrea CN</pubmed_authors><pubmed_authors>Astier L</pubmed_authors><pubmed_authors>Zimmerli A</pubmed_authors><pubmed_authors>Cornet AD</pubmed_authors><pubmed_authors>van der Jagt M</pubmed_authors><pubmed_authors>Chavez MJR</pubmed_authors><pubmed_authors>Porter J</pubmed_authors><pubmed_authors>Rocco M</pubmed_authors><pubmed_authors>Perez-Torres D</pubmed_authors><pubmed_authors>Ortiz-Macias IX</pubmed_authors><pubmed_authors>Deana C</pubmed_authors><pubmed_authors>Lasocki S</pubmed_authors><pubmed_authors>Stevens RD</pubmed_authors><pubmed_authors>Chabanne R</pubmed_authors><pubmed_authors>Barbosa-Camacho FJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical practice and effect of carbon dioxide on outcomes in mechanically ventilated acute brain-injured patients: a secondary analysis of the ENIO study.</name><description>&lt;h4>Purpose&lt;/h4>The use of arterial partial pressure of carbon dioxide (PaCO&lt;sub>2&lt;/sub>) as a target intervention to manage elevated intracranial pressure (ICP) and its effect on clinical outcomes remain unclear. We aimed to describe targets for PaCO&lt;sub>2&lt;/sub> in acute brain injured (ABI) patients and assess the occurrence of abnormal PaCO&lt;sub>2&lt;/sub> values during the first week in the intensive care unit (ICU). The secondary aim was to assess the association of PaCO&lt;sub>2&lt;/sub> with in-hospital mortality.&lt;h4>Methods&lt;/h4>We carried out a secondary analysis of a multicenter prospective observational study involving adult invasively ventilated patients with traumatic brain injury (TBI), subarachnoid hemorrhage (SAH), intracranial hemorrhage (ICH), or ischemic stroke (IS). PaCO&lt;sub>2&lt;/sub</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-07-14T21:19:48.659Z</modification><creation>2025-04-04T20:41:12.444Z</creation></dates><accession>S-EPMC10907416</accession><cross_references><pubmed>38294526</pubmed><doi>10.1007/s00134-023-07305-3</doi></cross_references></HashMap>